The quest for targetable pain mechanisms in 2024

IF 29.4 1区医学 Q1 RHEUMATOLOGY

Nature Reviews Rheumatology Pub Date : 2024-11-25 DOI:10.1038/s41584-024-01195-5

Neil Basu

引用次数: 0

Abstract

Studies published in 2024 suggest that although the repurposing of established rheumatology drugs seems to deliver incremental benefits for pain management, greater benefits could be gained in the future by targeting newly discovered pain mechanisms.

查看原文本刊更多论文

2024 年对可定位疼痛机制的探索

2024 年发表的研究表明，虽然重新利用已有的风湿病药物似乎能为疼痛治疗带来增量效益，但未来针对新发现的疼痛机制可能会带来更大的效益。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Nature Reviews Rheumatology 医学-风湿病学

CiteScore

29.90

自引率

0.90%

发文量

137

审稿时长

6-12 weeks

期刊介绍： Nature Reviews Rheumatology is part of the Nature Reviews portfolio of journals. The journal scope covers the entire spectrum of rheumatology research. We ensure that our articles are accessible to the widest possible audience.